Binocs for CGT: helping to streamline advanced therapy treatments
Providing specialized systems to cell and gene therapy developers and CDMOs
Precision scheduling tailored to CGT manufacturing
Binocs allows production sites to dynamically plan personnel and equipment for specialist ATMP processing.
- AI-enhanced scheduling: plan all CGT-related manufacturing tasks, including QC tests, QA oversight, and facilities support with to-the-minute precision.
- Resource conflict resolution: handle unexpected events and uncertainties and resolve resource constraints in real-time.
- Advanced competency-based planning: enhance the quality of cell processing by ensuring that the technicians with the right expertise are assigned to advanced production tasks.
- Shared calendar views: one view across all teams: connecting manufacturing, QC and QA teams in a real-time up to date view accessible for the full site.
- Constraint-based scheduling: automated sequencing of dependent activities to ensure that time-critical production runs are delivered in time.
- Full resource support: effortlessly incorporate specialist equipment and clean rooms into scheduled plans to ensure availability for manufacturing slots.
Patient-centric treatment slots
We understand the critical role of the patient in autologous therapies and just how important it is that their tissue collection visits are kept to a minimum. That’s why our treatment slot picker is designed to improve the chance of their tissue being processed within the viability window.
- Seamless interoperability with treatment center phasing platforms: Binocs integration replaces back-and-forth manual communication between ClinOps, PatientOps, and Manufacturing Operations.
- Guaranteeing a manufacturing slot: because Binocs knows when production windows will be open weeks in advance, it can work backards to identify tissue collection slots that will coincide with manufacturing availability.
- Custom treatment slot picker: treatment sites can select an appropriate dates and times for tissue collection based on patient and manufacturing availability, and expected transit time.
- Automated liaison between HCP and manufacturer: reduce e-mail and phone communication between PatientOps and ClinOps required to coordinate a suitable manufacturing window.
Providing planning visibility across the CGT supply chain
- Detailed capacity forecasting: therapy developers and CDMOs can significantly ramp-up CGT production slot availability by more than 20%.
- Scenario planning: evaluate the impact of different demand forecasts and how slots are allocated across the different manufacturing sites.
- Ramp-up your manufacturing operations: confidently evaluate how onboarding new personnel, variable training lead times, and additional clean room infrastructure impacts the number of slots across multiple products.